Experimental Drug Extended Animal Lifespans
Researchers have discovered that the drug 991 can increase the lifespan of certain animals by 25 percent.
Updated on Sept. 29, 2026 in Life Sciences
Live Poll
Do you believe breakthroughs in animal aging research warrant high expectations for human clinical trials?
A new study reveals that an experimental drug known as 991 significantly extends the lifespans of yeast, worms, and flies. By targeting the AMPK protein, the treatment increases longevity by up to 25 percent.
Why it matters
The AMPK protein acts as a critical cellular fuel gauge that regulates metabolism, inflammation, and cellular repair. Understanding how to modulate this protein could offer new insights into slowing processes linked to biological aging.
Researchers tested the drug 991 on fission yeast, nematode worms, and fruit flies to measure its impact on longevity. The study found the compound successfully triggers the AMPK protein to activate energy-conserving mechanisms in all three species.
The players
Medical Research Council
This United Kingdom government agency provided the primary funding for the longevity study.
Aging Cell
This scientific journal serves as the platform where the findings on drug 991 were published.
The details
The drug functions by directly activating the AMPK protein, which monitors energy availability within cells to maintain homeostasis. By signaling these pathways, the drug induces biological responses that enhance cellular maintenance.
Timeline
The study results were officially published in September 2026.
Deeper Dive
This study aligns with the broader research goals of the Medical Research Council, which funds investigations into the biological mechanisms of human health. The work marks a significant shift in gerontological research by focusing on specific protein-targeting interventions.
While this drug has only been tested on yeast, worms, and flies, the research lays the groundwork for future experiments in mammals. If successful in mice, these findings could eventually inform the development of human therapies targeting age-related decline.
The takeaway
Targeting the AMPK protein shows potential as a way to enhance cellular repair and slow the effects of aging. Further studies will determine if these laboratory results can be successfully translated into more complex animal models.
Further reading
For more information on current discoveries in aging research, visit Life Sciences.
Live Poll
Do you believe breakthroughs in animal aging research warrant high expectations for human clinical trials?
